SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-059159
Filing Date
2023-12-22
Accepted
2023-12-22 16:15:31
Documents
14
Period of Report
2023-12-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20017313_8k.htm   iXBRL 8-K 44841
2 JOINT PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY AND KARUNA THERAPEUTICS, INC ef20017313_ex99-1.htm EX-99.1 35407
  Complete submission text file 0001140361-23-059159.txt   282749

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20231222.xsd EX-101.SCH 4697
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20231222_def.xml EX-101.DEF 18375
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20231222_lab.xml EX-101.LAB 28470
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20231222_pre.xml EX-101.PRE 20674
8 EXTRACTED XBRL INSTANCE DOCUMENT ef20017313_8k_htm.xml XML 8284
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 231509977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)